| 发明名称 |
Use of fulvestrant in the treatment of resistant breast cancer |
| 摘要 |
<p>The invention relates to the use of fulvestrant in the treatment of breast cancer in patients who have previously been treated with an Selective Estrogen Receptor Modulator (SERM) and an aromatase inhibitor.</p> |
| 申请公布号 |
HU230064(B1) |
申请公布日期 |
2015.06.29 |
| 申请号 |
HU20030000339 |
申请日期 |
2001.04.02 |
| 申请人 |
ASTRAZENECA AB |
发明人 |
THURLIMANN BEAT |
| 分类号 |
A61K31/565;A61K31/138;A61K31/4196;A61K31/56;A61P35/00;A61P43/00;C07J1/00 |
主分类号 |
A61K31/565 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
